检索结果-内蒙古大学图书馆

An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial

引用

European urology oncology 2025年

作者： Penelope Schofield Stephen Quinn Natalie Richards Alan White Fiona White Mark Frydenberg Suzanne Chambers Louisa G Gordon Robert Alexander 'Frank' Gardiner Declan G Murphy Matthew J Roberts John Yaxley Nathan Lawrentschuk Kevin Chu Jeremy Millar Jeremy Grummet Ilona Juraskova School of Computing Engineering and Mathematical Sciences La Trobe University Melbourne Victoria Australia Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville Victoria Australia Department of Psychological Sciences Swinburne University of Technology Melbourne Victoria Australia. Electronic address: p.schofield@latrobe.edu.au. Department of Health Science and Biostatistics Swinburne University of Technology Melbourne Victoria Australia. Department of Health Sciences Research Peter MacCallum Cancer Centre Melbourne Victoria Australia. Department of Urology Cabrini Institute Cabrini Health Melbourne Victoria Australia Department of Surgery Monash University Melbourne Victoria Australia. Faculty of Health Sciences Australian Catholic University Brisbane Queensland Australia Health and Wellness Institute Edith Cowan University Perth Australia Menzies Health Institute Queensland Griffith University Southport Australia. Population Health Program Health Economics QIMR Berghofer Medical Research Institute Brisbane Queensland Australia School of Nursing Queensland University of Technology (QUT) Brisbane Queensland Australia School of Public Health The University of Queensland Brisbane Queensland Australia. The University of Queensland Brisbane Queensland Australia The University of Queensland Centre for Clinical Research Brisbane Queensland Australia The Royal Brisbane & Women's Hospital Herston Queensland Australia Edith Cowan University Perth Western Australia Griffith University Queensland Australia. Division of Cancer Surgery Peter MacCallum Cancer Centre Melbourne Victoria Australia. Department of Urology Royal Brisbane and Women's Hospital Herston Queensland Australia Department of Urology Redcliffe Hospital Redcliffe Queensland Australia. The University of Queensland Brisbane Queensland Australia. Department of Surgery The University of Melbourne Melbourne Victoria Australia Department of Urology The Ro

BACKGROUND AND OBJECTIVE:Evidence suggests that curative treatment for low-risk prostate cancer (LRPC) has no survival benefits over active surveillance (AS); thus, treatment choice becomes a value-sensitive decision. Decision aids (DAs) have the potential to facilitate this process, yet no DA has been tailored to the Australian health care system or population. This study aims to evaluate the impact of an online DA (Navigate) on the uptake of AS, quality of life, and decision-making in Australia. METHODS:This parallel-group, prospective, randomised controlled trial recruited men (from May 2017 to May 2021) from participating cancer centres, via self-referral, or via clinician referral. The inclusion criteria were the following: a recent LRPC diagnosis, no decision on treatment, and clinical suitability for AS. Partners could also enrol. Assessments were undertaken at baseline (before decision) and after baseline (1, 2, and 6 mo). Participants were randomised 1:1 to Navigate (online DA, intervention) or a national prostate cancer website (usual care), stratified by the site/recruitment method. Partners were allocated to the group matching their respective partners. The primary outcome was self-reported uptake of AS for first-line treatment at 1 mo. The secondary outcomes included decision-making preparedness; decisional conflict, regret, and satisfaction; illness communication; and prostate cancer-specific quality of life. Intention-to-treat analyses were conducted. KEY FINDINGS AND LIMITATIONS:Of the 619 patients referred, those eligible (n = 302) were randomised to either Navigate (n = 153) or usual care (n = 149), with no significant between-group differences at baseline. The proportion of men self-reporting AS versus another treatment was 90.6% (Navigate) versus 79.0% (usual care; p = 0.008). Navigate participants also reported greater decision-making preparedness (p < 0.001). Partners were allocated to Navigate (n = 70) or usual care (n = 49); no significant be

关键词： Active surveillance Decision support techniques Domestic partners Internet-based intervention Prostate cancer Randomised controlled trial

来源：评论

学校读者我要写书评

暂无评论

Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021

引用

The Lancet Public Health 2025年第3期10卷 e172-e188页

作者： Steel, Nicholas Bauer-Staeb, Clarissa Maria Mercedes Ford, John A. Abbafati, Cristiana Abdalla, Mohammed Altigani Abdelkader, Atef Abdi, Parsa Zuñiga, Roberto Ariel Abeldaño Abiodun, Olugbenga Olusola Abolhassani, Hassan Abu-Gharbieh, Eman Abukhadijah, Hana J. Abu-Zaid, Ahmed Addo, Isaac Yeboah Addolorato, Giovanni Adekanmbi, Victor Adetunji, Juliana Bunmi Adeyeoluwa, Temitayo Esther Agardh, Emilie E. Agyemang-Duah, Williams Ahmad, Danish Ahmed, Ayman Ahmed, Syed Anees Akinosoglou, Karolina Akkaif, Mohammed Ahmed Al Awaidy, Salah Al Hasan, Syed Mahfuz Al Zaabi, Omar Ali Mohammed Aldridge, Robert W. Algammal, Abdelazeem M. Al-Gheethi, Adel Ali Saeed Ali, Abid Ali, Mohammed Usman Ali, Syed Shujait Ali, Waad Alicandro, Gianfranco Alif, Sheikh Mohammad Al-Jumaily, Adel Allebeck, Peter Alrawashdeh, Ahmad Al-Rifai, Rami H. Alsabri, Mohammed A. Alshahrani, Najim Z. Aluh, Deborah Oyine Al-Wardat, Mohammad Al-Zyoud, Walid A. Amiri, Sohrab Anderlini, Deanna Andrei, Catalina Liliana Anil, Abhishek Anvari, Saeid Anyasodor, Anayochukwu Edward Appiah, Seth Christopher Yaw Aquilano, Michele Arabloo, Jalal Arafat, Mosab Areda, Demelash Aremu, Abdulfatai Armani, Keivan Armocida, Benedetta Ärnlöv, Johan Asaduzzaman, Muhammad Astell-Burt, Thomas Aujayeb, Avinash Ausloos, Marcel Azadnajafabad, Sina Aziz, Shahkaar Azzam, Ahmed Y. Babu, Giridhara Rathnaiah Badache, Andreea Corina Badiye, Ashish D. Bahramian, Saeed Baig, Atif Amin Baker, Jennifer L. Bansal, Hansi Bärnighausen, Till Winfried Barone, Mark Thomaz Ugliara Barrow, Amadou Barteit, Sandra Bashir, Shahid Bashiru, Hameed Akande Basso, João Diogo Bastan, Mohammad-Mahdi Basu, Sanjay Batra, Kavita Bauckneht, Matteo Baune, Bernhard T. Beghi, Massimiliano Beiranvand, Maryam Béjot, Yannick Bell, Michelle L. Bello, Olorunjuwon Omolaja Belo, Luis Beloukas, Apostolos Beneke, Alice A. Bettencourt, Paulo J.G. Bhagavathula, Akshaya Srikanth Bhala, Neeraj Bhaskar, Sonu Bisulli, Francesca Bjørge, Tone Bodunrin, Aadam Olalekan Carvajal, Alejandro Botero Bouaoud, Souad Brayne, Carol Brenner, H Department of Primary Care and Public Health University of East Anglia Norwich United Kingdom Office for Health Improvement and Disparities Department of Health and Social Care London United Kingdom Department of Legal and Economic Studies La Sapienza University Rome Italy Rome Italy Hull York Medical School University of Hull Hull United Kingdom Department of Mathematics and Sciences Ajman University Ajman United Arab Emirates Department of Medicine Memorial University St. John's NL Canada Postgraduate Department University of Sierra Sur Miahuatlan de Porfirio Diaz Mexico Yhteiskuntadatatieteen keskus (Centre for Social Data Science) Helsinki Finland Department of Internal Medicine Federal Medical Centre Abuja Nigeria Research Center for Immunodeficiencies Tehran University of Medical Sciences Tehran Iran Department of Medical Biochemistry and Biophysics Karolinska Institutet (Karolinska Institute) Stockholm Sweden Department of Clinical Sciences University of Sharjah Sharjah United Arab Emirates Department of Biopharmaceutics and Clinical Pharmacy University of Jordan Amman Jordan Medical Research Center Hamad Medical Corporation Doha Qatar Department of Biochemistry and Molecular Medicine Alfaisal University Riyadh Saudi Arabia College of Graduate Health Sciences University of Tennessee Memphis TN United States School of Medicine Sydney NSW Australia Centre for Social Research in Health University of New South Wales Sydney NSW Australia Internal Medicine and Alcohol Related Disease Unit Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy Department of Medical and Surgical Sciences Università Cattolica di Roma (Catholic University of Rome) Rome Italy Department of Obstetrics and Gynecology University of Texas Medical Branch Galveston TX United States Department of Biochemistry Osun State University Osogbo Nigeria Department of Pharmacology and Therapeutics University of Medical Sciences Ondo Ondo Nigeria Department of Veteri

Background: Decades of steady improvements in life expectancy in Europe slowed down from around 2011, well before the COVID-19 pandemic, for reasons which remain disputed. We aimed to assess how changes in risk factors and cause-specific death rates in different European countries related to changes in life expectancy in those countries before and during the COVID-19 pandemic. Methods: We used data and methods from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 to compare changes in life expectancy at birth, causes of death, and population exposure to risk factors in 16 European Economic Area countries (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, and Sweden) and the four UK nations (England, Northern Ireland, Scotland, and Wales) for three time periods: 1990–2011, 2011–19, and 2019–21. Changes in life expectancy and causes of death were estimated with an established life expectancy cause-specific decomposition method, and compared with summary exposure values of risk factors for the major causes of death influencing life expectancy. Findings: All countries showed mean annual improvements in life expectancy in both 1990–2011 (overall mean 0·23 years [95% uncertainty interval [UI] 0·23 to 0·24]) and 2011–19 (overall mean 0·15 years [0·13 to 0·16]). The rate of improvement was lower in 2011–19 than in 1990–2011 in all countries except for Norway, where the mean annual increase in life expectancy rose from 0·21 years (95% UI 0·20 to 0·22) in 1990–2011 to 0·23 years (0·21 to 0·26) in 2011–19 (difference of 0·03 years). In other countries, the difference in mean annual improvement between these periods ranged from –0·01 years in Iceland (0·19 years [95% UI 0·16 to 0·21] vs 0·18 years [0·09 to 0·26]), to –0·18 years in England (0·25 years [0·24 to 0·25] vs 0·07 years [0·06 to 0·08]). In 2019–21, there was an overall decrease in mean annual life expectancy a

关键词：

来源：评论

学校读者我要写书评

暂无评论

The eROSITA final equatorial-depth survey (eFEDS): Optical confirmation, redshifts, and properties of the cluster and group catalog

arXiv

引用

arXiv 2021年

作者： Klein, Matthias Oguri, M. Mohr, J.J. Grandis, S. Ghirardini, V. Liu, T. Liu, A. Bulbul, E. Wolf, J. Comparat, J. Ramos-Ceja, M.E. Buchner, J. Chiu, I. Clerc, N. Merloni, A. Miyatake, H. Miyazaki, S. Okabe, N. Ota, N. Pacaud, F. Salvato, M. Driver, S.P. Faculty of Physics Ludwig-Maximilians-Universität Scheinerstr. 1 Munich81679 Germany Research Center for the Early Universe University of Tokyo Tokyo113-0033 Japan Department of Physics University of Tokyo Tokyo113-0033 Japan University of Tokyo Chiba277-8582 Japan Max Planck Institute for Extraterrestrial Physics Giessenbachstrasse 1 Garching85748 Germany Tsung-Dao Lee Institute Key Laboratory for Particle Physics Astrophysics and Cosmology Ministry of Education Shanghai Jiao Tong University Shanghai200240 China Department of Astronomy School of Physics and Astronomy Shanghai Key Laboratory for Particle Physics and Cosmology Shanghai Jiao Tong University Shanghai200240 China 11F of AS/NTU Astronomy-Mathematics Building No.1 Sec. 4 Roosevelt Rd Taipei10617 Taiwan IRAP Université de Toulouse CNRS UPS CNES Toulouse France Nagoya University Nagoya464-8602 Japan National Astronomical Observatory of Japan 2-21-1 Osawa Mitaka Tokyo181-8588 Japan Mitaka Tokyo181-8588 Japan Physics Program Graduate School of Advanced Science and Engineering Hiroshima University 1-3-1 Kagamiyama Higashi-Hiroshima Hiroshima739-8526 Japan Hiroshima Astrophysical Science Center Hiroshima University 1-3-1 Kagamiyama Higashi-Hiroshima Hiroshima739-8526 Japan Core Research for Energetic Universe Hiroshima University 1-3-1 Kagamiyama Higashi-Hiroshima Hiroshima739-8526 Japan Universität Bonn Auf dem Hügel 71 Bonn53121 Germany Department of Physics Nara Women’s University Kitauoyanishimachi Nara630-8506 Japan CRAR The University of Western Australia 7 Fairway CrawleyWA6009 Australia Exzellenzcluster ORIGINS Boltzmannstr. 2 GarchingD-85748 Germany

Context. In 2019, the eROSITA telescope on board of the Russian-German satellite Spectrum-Roentgen-Gamma (SRG), has started to perform a deep all-sky X-ray survey with the aim of identifying ∼ 100, 000 clusters and groups over the course of four years. As part of its performance verification phase a ∼ 140 deg2 survey called eROSITA Final Equatorial-Depth Survey (eFEDS) was performed. With a depth typical of the all-sky survey after four years, it allows tests of tools and methods as well as improved predictions for the all-sky survey. Aims. As part of this effort, a catalog of 542 X-ray extent selected galaxy group and cluster candidates was constructed. In this paper we present the optical follow-up with the aim of providing redshifts and cluster confirmation for the full sample. Further we aim to provide additional information on cluster dynamical state, cluster richness and cluster optical centre. Finally we aim to evaluate the impact of optical cluster confirmation on the purity and completeness of the X-ray selected sample. Methods. We use optical imaging data from the Hyper Suprime-Cam Subaru Strategic program and from the Legacy Survey to identify optical counterparts to the X-ray detected cluster candidates. We make use of the red sequence based cluster redshift and confirmation tool MCMF as well as the optical cluster finder CAMIRA to derive cluster redshifts and richnesses. MCMF provided probabilities of an optical structure being a chance super position with the X-ray candidate is used to identify the best optical counter part as well as to confirm an X-ray candidate as a cluster. The impact of this confirmation process on catalog purity and completeness is estimated using optical to X-ray scaling relations as well as simulations. The resulting catalog is further matched with public group and cluster catalogs. Optical estimators of cluster dynamical state are constructed based on density maps of the red sequence galaxies at the cluster redshift. Results.

关键词： Surveys

来源：评论

学校读者我要写书评

暂无评论

Patterns of somatic structural variation in human cancer genomes (vol 578, pg 112, 2020)

引用

NATURE 2023年第7948期614卷 E38-E38页

作者： Li, Yilong Roberts, Nicola D. Wala, Jeremiah A. Shapira, Ofer Schumacher, Steven E. Kumar, Kiran Khurana, Ekta Waszak, Sebastian Korbel, Jan O. Haber, James E. Imielinski, Marcin Weischenfeldt, Joachim Beroukhim, Rameen Campbell, Peter J. Cancer Genome Project Wellcome Trust Sanger Institute Hinxton UK Totient Inc Cambridge MA USA Wellcome Sanger Institute Wellcome Genome Campus Hinxton UK Department of Haematology University of Cambridge Cambridge UK Cambridge University Hospitals NHS Foundation Trust Cambridge UK Korea Advanced Institute of Science and Technology Daejeon South Korea Department of Zoology Genetics and Physical Anthropology University of Santiago de Compostela Santiago de Compostela Spain Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS) University of Santiago de Compostela Santiago de Compostela Spain The Biomedical Research Centre (CINBIO) University of Vigo Vigo Spain Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS) Universidade de Santiago de Compostela Santiago de Compostela Spain Department of Zoology Genetics and Physical Anthropology (CiMUS) Universidade de Santiago de Compostela Santiago de Compostela Spain The Biomedical Research Centre (CINBIO) Universidade de Vigo Vigo Spain The Broad Institute of Harvard and MIT Cambridge MA USA Bioinformatics and Integrative Genomics Harvard University Cambridge MA USA Department of Cancer Biology Dana-Farber Cancer Institute Boston MA USA Broad Institute of MIT and Harvard Cambridge MA USA Department of Medical Oncology Dana-Farber Cancer Institute Boston MA USA Harvard Medical School Boston MA USA Massachusetts General Hospital Center for Cancer Research Charlestown MA USA Dana-Farber Cancer Institute Boston MA USA Department of Biostatistics and Computational Biology Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA Weill Cornell Medical College New York NY USA Department of Physiology and Biophysics Weill Cornell Medicine New York NY USA Institute for Computational Biomedicine Weill Cornell Medicine New York NY USA Controlled Department and Institution New York NY USA Englander Institute for Precision Medicine Weill Cornell Medicine Ne

来源：评论

学校读者我要写书评

暂无评论

Study of flavor dependence of the baryon-to-meson ratio in proton-proton collisions at s=13 TeV

引用

Physical Review D 2023年第11期108卷 112003-112003页

作者： S. Acharya D. Adamová G. Aglieri Rinella M. Agnello N. Agrawal Z. Ahammed S. Ahmad S. U. Ahn I. Ahuja A. Akindinov M. Al-Turany D. Aleksandrov B. Alessandro H. M. Alfanda R. Alfaro Molina B. Ali A. Alici N. Alizadehvandchali A. Alkin J. Alme G. Alocco T. Alt A. R. Altamura I. Altsybeev M. N. Anaam C. Andrei N. Andreou A. Andronic V. Anguelov F. Antinori P. Antonioli N. Apadula L. Aphecetche H. Appelshäuser C. Arata S. Arcelli M. Aresti R. Arnaldi J. G. M. C. A. Arneiro I. C. Arsene M. Arslandok A. Augustinus R. Averbeck M. D. Azmi H. Baba A. Badalà J. Bae Y. W. Baek X. Bai R. Bailhache Y. Bailung A. Balbino A. Baldisseri B. Balis D. Banerjee Z. Banoo R. Barbera F. Barile L. Barioglio M. Barlou B. Barman G. G. Barnaföldi L. S. Barnby V. Barret L. Barreto C. Bartels K. Barth E. Bartsch N. Bastid S. Basu G. Batigne D. Battistini B. Batyunya D. Bauri J. L. Bazo Alba I. G. Bearden C. Beattie P. Becht D. Behera I. Belikov A. D. C. Bell Hechavarria F. Bellini R. Bellwied S. Belokurova G. Bencedi S. Beole Y. Berdnikov A. Berdnikova L. Bergmann M. G. Besoiu L. Betev P. P. Bhaduri A. Bhasin M. A. Bhat B. Bhattacharjee L. Bianchi N. Bianchi J. Bielčík J. Bielčíková J. Biernat A. P. Bigot A. Bilandzic G. Biro S. Biswas N. Bize J. T. Blair D. Blau M. B. Blidaru N. Bluhme C. Blume G. Boca F. Bock T. Bodova A. Bogdanov S. Boi J. Bok L. Boldizsár M. Bombara P. M. Bond G. Bonomi H. Borel A. Borissov A. G. Borquez Carcamo H. Bossi E. Botta Y. E. M. Bouziani L. Bratrud P. Braun-Munzinger M. Bregant M. Broz G. E. Bruno M. D. Buckland D. Budnikov H. Buesching S. Bufalino P. Buhler N. Burmasov Z. Buthelezi A. Bylinkin S. A. Bysiak M. Cai H. Caines A. Caliva E. Calvo Villar J. M. M. Camacho P. Camerini F. D. M. Canedo M. Carabas A. A. Carballo F. Carnesecchi R. Caron L. A. D. Carvalho J. Castillo Castellanos F. Catalano C. Ceballos Sanchez I. Chakaberia P. Chakraborty S. Chandra S. Chapeland M. Chartier S. Chattopadhyay T. G. Chavez T. Cheng C. Cheshkov B. Cheynis V. Chibante Barroso D. D. Chinellato E. S. Chizzali J. Cho S. Cho P. Cho Université Clermont Auvergne CNRS/IN2P3 LPC Clermont-Ferrand France Nuclear Physics Institute of the Czech Academy of Sciences Husinec-Řež Czech Republic European Organization for Nuclear Research (CERN) Geneva Switzerland Dipartimento DISAT del Politecnico and Sezione INFN Turin Italy INFN Sezione di Bologna Bologna Italy Variable Energy Cyclotron Centre Homi Bhabha National Institute Kolkata India Department of Physics Aligarh Muslim University Aligarh India Korea Institute of Science and Technology Information Daejeon Republic of Korea Faculty of Science P.J. Šafárik University Košice Slovak Republic Affiliated with an institute covered by a cooperation agreement with CERN Research Division and ExtreMe Matter Institute EMMI GSI Helmholtzzentrum für Schwerionenforschung GmbH Darmstadt Germany INFN Sezione di Torino Turin Italy Central China Normal University Wuhan China Instituto de Física Universidad Nacional Autónoma de México Mexico City Mexico Dipartimento di Fisica e Astronomia dell’Università Bologna Italy Sezione INFN Bologna Italy University of Houston Houston Texas USA Department of Physics and Technology University of Bergen Bergen Norway INFN Sezione di Cagliari Cagliari Italy Institut für Kernphysik Johann Wolfgang Goethe-Universität Frankfurt Frankfurt Germany INFN Sezione di Bari Bari Italy Physik Department Technische Universität München Munich Germany Horia Hulubei National Institute of Physics and Nuclear Engineering Bucharest Romania University of Derby Derby United Kingdom Universität Münster Institut für Kernphysik Münster Germany Physikalisches Institut Ruprecht-Karls-Universität Heidelberg Heidelberg Germany INFN Sezione di Padova Padova Italy Lawrence Berkeley National Laboratory Berkeley California USA SUBATECH IMT Atlantique Nantes Université CNRS-IN2P3 Nantes France Laboratoire de Physique Subatomique et de Cosmologie Université Grenoble-Alpes CNRS-IN2P3 Grenoble France Dipartimento di Fisica dell’Univers

The production cross sections of D0 and Λc+ hadrons originating from beauty-hadron decays (i.e., nonprompt) were measured for the first time at midrapidity (|y|<0.5) by the ALICE Collaboration in proton-proton collisions at a center-of-mass energy s=13 TeV. They are described within uncertainties by perturbative QCD calculations employing the fragmentation fractions of beauty quarks to baryons measured at forward rapidity by the LHCb Collaboration. The bb¯ production cross section per unit of rapidity at midrapidity, estimated from these measurements, is dσbb¯/dy||y|<0.5=83.1±3.5(stat)±5.4(syst)−3.2+12.3(extrap) μb. The baryon-to-meson ratios are computed to investigate the hadronization mechanism of beauty quarks. The nonprompt Λc+/D0 production ratio has a similar trend to the one measured for the promptly produced charmed particles and to the p/π+ and Λ/KS0 ratios, suggesting a similar baryon-formation mechanism among light, strange, charm, and beauty hadrons. The pT -integrated nonprompt Λc+/D0 ratio is found to be significantly higher than the one measured in e+e− collisions.

关键词： Hadron-hadron interactions Particle production Bottom quark

来源：评论

学校读者我要写书评

暂无评论

Pseudorapidity densities of charged particles with transverse momentum thresholds in pp collisions at s=5.02 and 13 TeV

引用

Physical Review D 2023年第7期108卷 072008-072008页

作者： S. Acharya D. Adamová A. Adler G. Aglieri Rinella M. Agnello N. Agrawal Z. Ahammed S. Ahmad S. U. Ahn I. Ahuja A. Akindinov M. Al-Turany D. Aleksandrov B. Alessandro H. M. Alfanda R. Alfaro Molina B. Ali A. Alici N. Alizadehvandchali A. Alkin J. Alme G. Alocco T. Alt I. Altsybeev M. N. Anaam C. Andrei A. Andronic V. Anguelov F. Antinori P. Antonioli N. Apadula L. Aphecetche H. Appelshäuser C. Arata S. Arcelli M. Aresti R. Arnaldi J. G. M. C. A. Arneiro I. C. Arsene M. Arslandok A. Augustinus R. Averbeck M. D. Azmi A. Badalà J. Bae Y. W. Baek X. Bai R. Bailhache Y. Bailung A. Balbino A. Baldisseri B. Balis D. Banerjee Z. Banoo R. Barbera F. Barile L. Barioglio M. Barlou G. G. Barnaföldi L. S. Barnby V. Barret L. Barreto C. Bartels K. Barth E. Bartsch N. Bastid S. Basu G. Batigne D. Battistini B. Batyunya D. Bauri J. L. Bazo Alba I. G. Bearden C. Beattie P. Becht D. Behera I. Belikov A. D. C. Bell Hechavarria F. Bellini R. Bellwied S. Belokurova V. Belyaev G. Bencedi S. Beole A. Bercuci Y. Berdnikov A. Berdnikova L. Bergmann M. G. Besoiu L. Betev P. P. Bhaduri A. Bhasin M. A. Bhat B. Bhattacharjee L. Bianchi N. Bianchi J. Bielčík J. Bielčíková J. Biernat A. P. Bigot A. Bilandzic G. Biro S. Biswas N. Bize J. T. Blair D. Blau M. B. Blidaru N. Bluhme C. Blume G. Boca F. Bock T. Bodova A. Bogdanov S. Boi J. Bok L. Boldizsár A. Bolozdynya M. Bombara P. M. Bond G. Bonomi H. Borel A. Borissov A. G. Borquez Carcamo H. Bossi E. Botta Y. E. M. Bouziani L. Bratrud P. Braun-Munzinger M. Bregant M. Broz G. E. Bruno M. D. Buckland D. Budnikov H. Buesching S. Bufalino O. Bugnon P. Buhler Z. Buthelezi S. A. Bysiak M. Cai H. Caines A. Caliva E. Calvo Villar J. M. M. Camacho P. Camerini F. D. M. Canedo M. Carabas A. A. Carballo F. Carnesecchi R. Caron L. A. D. Carvalho J. Castillo Castellanos F. Catalano C. Ceballos Sanchez I. Chakaberia P. Chakraborty S. Chandra S. Chapeland M. Chartier S. Chattopadhyay T. G. Chavez T. Cheng C. Cheshkov B. Cheynis V. Chibante Barroso D. D. Chinellato E. S. Chizzali J. Cho S. Cho P. Chochula P. Chri Université Clermont Auvergne CNRS/IN2P3 LPC Clermont-Ferrand France Nuclear Physics Institute of the Czech Academy of Sciences Husinec-Řež Czech Republic Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik Fachbereich Informatik und Mathematik Frankfurt Germany European Organization for Nuclear Research (CERN) Geneva Switzerland Dipartimento DISAT del Politecnico and Sezione INFN Turin Italy INFN Sezione di Bologna Bologna Italy Variable Energy Cyclotron Centre Homi Bhabha National Institute Kolkata India Department of Physics Aligarh Muslim University Aligarh India Korea Institute of Science and Technology Information Daejeon Republic of Korea Faculty of Science P.J. Šafárik University Košice Slovak Republic Affiliated with an institute covered by a cooperation agreement with CERN Research Division and ExtreMe Matter Institute EMMI GSI Helmholtzzentrum für Schwerionenforschung GmbH Darmstadt Germany INFN Sezione di Torino Turin Italy Central China Normal University Wuhan China Instituto de Física Universidad Nacional Autónoma de México Mexico City Mexico Dipartimento di Fisica e Astronomia dell’Università Bologna Italy Sezione INFN Bologna Italy University of Houston Houston Texas USA Department of Physics and Technology University of Bergen Bergen Norway INFN Sezione di Cagliari Cagliari Italy Institut für Kernphysik Johann Wolfgang Goethe-Universität Frankfurt Frankfurt Germany Horia Hulubei National Institute of Physics and Nuclear Engineering Bucharest Romania Westfälische Wilhelms-Universität Münster Institut für Kernphysik Münster Germany Physikalisches Institut Ruprecht-Karls-Universität Heidelberg Heidelberg Germany INFN Sezione di Padova Padova Italy Lawrence Berkeley National Laboratory Berkeley California USA SUBATECH IMT Atlantique Nantes Université CNRS-IN2P3 Nantes France Laboratoire de Physique Subatomique et de Cosmologie Université Grenoble-Alpes CNRS-IN2P3 Grenoble France Universidade de São Paulo (USP

The pseudorapidity density of charged particles with minimum transverse momentum (pT) thresholds of 0.15, 0.5, 1, and 2 GeV/c is measured in pp collisions at the center of mass energies of s=5.02 and 13 TeV with the ALICE detector. The study is carried out for inelastic collisions with at least one primary charged particle having a pseudorapidity (η) within ±0.8 and pT larger than the corresponding threshold. In addition, measurements without pT-thresholds are performed for inelastic and nonsingle-diffractive events as well as for inelastic events with at least one charged particle having |η|<1 in pp collisions at s=5.02 TeV for the first time at the LHC. These measurements are compared to the pythia 6, pythia 8, and epos-lhc models. In general, the models describe the η dependence of particle production well. However, discrepancies are observed for the highest transverse momentum threshold (pT>2 GeV/c), highlighting the importance of such measurements for tuning event generators. The new measurements agree within uncertainties with results from the ATLAS and CMS experiments obtained at s=13 TeV.

关键词： Hadron-hadron interactions Particle production QCD phenomenology

来源：评论

学校读者我要写书评

暂无评论

The evolutionary history of 2,658 cancers (vol 578, pg 122, 2020)

引用

NATURE 2023年第7948期614卷 E42-E42页

作者： Gerstung, Moritz Jolly, Clemency Leshchiner, Ignaty Dentro, Stefan C. Gonzalez, Santiago Rosebrock, Daniel Mitchell, Thomas J. Rubanova, Yulia Anur, Pavana Yu, Kaixian Tarabichi, Maxime Deshwar, Amit Wintersinger, Jeff Kleinheinz, Kortine Vazquez-Garcia, Ignacio Haase, Kerstin Jerman, Lara Sengupta, Subhajit Macintyre, Geoff Malikic, Salem Donmez, Nilgun Livitz, Dimitri G. Cmero, Marek Demeulemeester, Jonas Schumacher, Steven Fan, Yu Yao, Xiaotong Lee, Juhee Schlesner, Matthias Boutros, Paul C. Bowtell, David D. Zhu, Hongtu Getz, Gad Imielinski, Marcin Beroukhim, Rameen Sahinalp, S. Cenk Ji, Yuan Peifer, Martin Markowetz, Florian Mustonen, Ville Yuan, Ke Wang, Wenyi Morris, Quaid D. Spellman, Paul T. Wedge, David C. Van Loo, Peter European Molecular Biology Laboratory European Bioinformatics Institute (EMBL-EBI) Cambridge UK European Molecular Biology Laboratory Genome Biology Unit Heidelberg Germany Wellcome Sanger Institute Cambridge UK Genome Biology Unit European Molecular Biology Laboratory (EMBL) Heidelberg Germany University of Ljubljana Ljubljana Slovenia The Francis Crick Institute London UK Big Data Institute University of Oxford Oxford UK Wellcome Sanger Institute Wellcome Genome Campus Hinxton UK Big Data Institute Li Ka Shing Centre University of Oxford Oxford UK University of Cambridge Cambridge UK Cambridge University Hospitals NHS Foundation Trust Cambridge UK Department of Applied Mathematics and Theoretical Physics Centre for Mathematical Sciences University of Cambridge Cambridge UK Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York NY USA Department of Statistics Columbia University New York NY USA Department of Haematology University of Cambridge Cambridge UK University of Leuven Leuven Belgium Broad Institute of MIT and Harvard Cambridge MA USA Center for Cancer Research Massachusetts General Hospital Charlestown MA USA Department of Pathology Massachusetts General Hospital Boston MA USA Harvard Medical School Boston MA USA Center for Cancer Research Massachusetts General Hospital Boston MA USA Dana-Farber Cancer Institute Boston MA USA Department of Medical Oncology Dana-Farber Cancer Institute Boston MA USA Department of Cancer Biology Dana-Farber Cancer Institute Boston MA USA Oxford NIHR Biomedical Research Centre Oxford UK Oxford NIHR Biomedical Research Centre University of Oxford Oxford UK University of Toronto Toronto Ontario Canada Vector Institute Toronto Ontario Canada Vector Institute Toronto ON Canada Department of Computer Science University of Toronto Toronto ON Canada Ontario Institute for Cancer Research Toronto Ontario Canada University of California Los Angeles

来源：评论

学校读者我要写书评

暂无评论

3D Printed frames to enable reuse and improve the fit of N95 and KN95 respirators

引用

BMC biomedical engineering 2021年第1期3卷 10页

作者： Malia McAvoy Ai-Tram N Bui Christopher Hansen Deborah Plana Jordan T Said Zizi Yu Helen Yang Jacob Freake Christopher Van David Krikorian Avilash Cramer Leanne Smith Liwei Jiang Karen J Lee Sara J Li Brandon Beller Kimberley Huggins Michael P Short Sherry H Yu Arash Mostaghimi Peter K Sorger Nicole R LeBoeuf Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science Harvard Medical School Boston MA USA. Department of Neurosurgery University of Washington Seattle WA USA. Harvard Medical School Boston MA USA. Harvard Graduate School of Design Cambridge MA USA. Harvard-MIT Division of Health Sciences and Technology Cambridge MA USA. Department of Systems Biology Harvard Ludwig Cancer Research Center Harvard Medical School Boston MA USA. Harvard-MIT Center for Regulatory Science Harvard Medical School Boston MA USA. Fikst Product Development Woburn MA USA. Borobot Middleborough MA USA. Dana-Farber Cancer Institute MA Boston USA. Department of Radiology Brigham and Women's Hospital Boston MA USA. Department of Dermatology Brigham and Women's Hospital Boston MA USA. Engineering Science at Norwalk Community College Norwalk CT USA. Department of Nuclear Science and Engineering Massachusetts Institute of Technology Cambridge MA USA. Department of Dermatology Yale University School of Medicine New Haven CT USA. Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science Harvard Medical School Boston MA USA. peter_sorger@hms.harvard.edu. Department of Systems Biology Harvard Ludwig Cancer Research Center Harvard Medical School Boston MA USA. peter_sorger@hms.harvard.edu. Harvard Program in Therapeutic Science Harvard Medical School Boston MA USA. peter_sorger@hms.harvard.edu. Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science Harvard Medical School Boston MA USA. nleboeuf@bwh.harvard.edu. Harvard Medical School Boston MA USA. nleboeuf@bwh.harvard.edu. Dana-Farber Cancer Institute MA Boston USA. nleboeuf@bwh.harvard.edu. Department of Dermatology Brigham and Women's Hospital Boston MA USA. nleboeuf@bwh.harvard.edu.

BACKGROUND:In response to supply shortages caused by the COVID-19 pandemic, N95 filtering facepiece respirators (FFRs or "masks"), which are typically single-use devices in healthcare settings, are routinely being used for prolonged periods and in some cases decontaminated under "reuse" and "extended use" policies. However, the reusability of N95 masks is limited by degradation of fit. Possible substitutes, such as KN95 masks meeting Chinese standards, frequently fail fit testing even when new. The purpose of this study was to develop an inexpensive frame for damaged and poorly fitting masks using readily available materials and 3D printing. RESULTS:An iterative design process yielded a mask frame consisting of two 3D printed side pieces, malleable wire links that users press against their face, and cut lengths of elastic material that go around the head to hold the frame and mask in place. Volunteers (n = 45; average BMI = 25.4), underwent qualitative fit testing with and without mask frames wearing one or more of four different brands of FFRs conforming to US N95 or Chinese KN95 standards. Masks passed qualitative fit testing in the absence of a frame at rates varying from 48 to 94 % (depending on mask model). For individuals who underwent testing using respirators with broken or defective straps, 80-100 % (average 85 %) passed fit testing with mask frames. Among individuals who failed fit testing with a KN95, ~ 50 % passed testing by using a frame. CONCLUSIONS:Our study suggests that mask frames can prolong the lifespan of N95 and KN95 masks by serving as a substitute for broken or defective bands without adversely affecting fit. Use of frames made it possible for ~ 73 % of the test population to achieve a good fit based on qualitative and quantitative testing criteria, approaching the 85-90 % success rate observed for intact N95 masks. Frames therefore represent a simple and inexpensive way of expanding access to PPE and extending their useful life. For clinicia

关键词： 3D printing COVID-19 KN95 masks N95 respirators filtering face piece (FFP) respirator mask frames occupational health pandemic response personal protective equipment (PPE) prototyping

来源：评论

学校读者我要写书评

暂无评论

Jet modification via π0-hadron correlations in Au+Au collisions at sNN=200 GeV

引用

Physical Review C 2024年第4期110卷 044901页

作者： N. J. Abdulameer U. Acharya A. Adare S. Afanasiev C. Aidala N. N. Ajitanand Y. Akiba H. Al-Bataineh J. Alexander M. Alfred K. Aoki N. Apadula L. Aphecetche J. Asai H. Asano E. T. Atomssa R. Averbeck T. C. Awes B. Azmoun V. Babintsev M. Bai G. Baksay L. Baksay A. Baldisseri N. S. Bandara B. Bannier K. N. Barish P. D. Barnes B. Bassalleck A. T. Basye S. Bathe S. Batsouli V. Baublis C. Baumann A. Bazilevsky M. Beaumier S. Beckman S. Belikov R. Belmont R. Bennett A. Berdnikov Y. Berdnikov L. Bichon A. A. Bickley B. Blankenship D. S. Blau J. G. Boissevain J. S. Bok H. Borel V. Borisov K. Boyle M. L. Brooks J. Bryslawskyj H. Buesching V. Bumazhnov G. Bunce S. Butsyk C. M. Camacho S. Campbell B. S. Chang W. C. Chang J. L. Charvet C.-H. Chen D. Chen S. Chernichenko M. Chiu C. Y. Chi I. J. Choi J. B. Choi R. K. Choudhury T. Chujo P. Chung A. Churyn V. Cianciolo Z. Citron B. A. Cole M. Connors P. Constantin R. Corliss M. Csanád T. Csörgő D. d'Enterria T. Dahms S. Dairaku T. W. Danley K. Das A. Datta M. S. Daugherity G. David K. DeBlasio K. Dehmelt A. Denisov A. Deshpande E. J. Desmond O. Dietzsch A. Dion P. B. Diss M. Donadelli V. Doomra J. H. Do O. Drapier A. Drees K. A. Drees A. K. Dubey J. M. Durham A. Durum D. Dutta V. Dzhordzhadze Y. V. Efremenko F. Ellinghaus H. En'yo T. Engelmore A. Enokizono R. Esha K. O. Eyser B. Fadem N. Feege D. E. Fields M. Finger, Jr. M. Finger D. Firak D. Fitzgerald F. Fleuret S. L. Fokin Z. Fraenkel J. E. Frantz A. Franz A. D. Frawley K. Fujiwara Y. Fukao T. Fusayasu P. Gallus C. Gal P. Garg I. Garishvili H. Ge F. Giordano A. Glenn H. Gong M. Gonin J. Gosset Y. Goto R. Granier de Cassagnac N. Grau S. V. Greene M. Grosse Perdekamp T. Gunji T. Guo H.-Å. Gustafsson T. Hachiya A. Hadj Henni J. S. Haggerty K. I. Hahn H. Hamagaki H. F. Hamilton J. Hanks R. Han S. Y. Han E. P. Hartouni K. Haruna S. Hasegawa T. O. S. Haseler K. Hashimoto E. Haslum R. Hayano M. Heffner T. K. Hemmick T. Hester X. He J. C. Hill A. Hodges M. Hohlmann R. S. Hollis W. Holzmann K. Homma B. Hong T. Horaguchi D. Hornback T. Debrecen University H-4010 Debrecen Egyetem tér 1 Hungary HUN-REN ATOMKI H-4026 Debrecen Bem tér 18/c Hungary Atlanta Georgia 30303 USA University of Colorado Boulder Colorado 80309 USA Joint Institute for Nuclear Research 141980 Dubna Moscow Region Russia Department of Physics University of Massachusetts Amherst Massachusetts 01003-9337 USA Department of Physics University of Michigan Ann Arbor Michigan 48109-1040 USA Chemistry Department Stony Brook University SUNY Stony Brook New York 11794-3400 USA RIKEN Nishina Center for Accelerator-Based Science Wako Saitama 351-0198 Japan RIKEN BNL Research Center New Mexico State University Las Cruces New Mexico 88003 USA Department of Physics and Astronomy Howard University Washington DC 20059 USA KEK High Energy Accelerator Research Organization Tsukuba Ibaraki 305-0801 Japan Kyoto University Kyoto 606-8502 Japan Iowa State University Ames Iowa 50011 USA Department of Physics and Astronomy Stony Brook University SUNY Stony Brook New York 11794-3800 USA SUBATECH (Ecole des Mines de Nantes CNRS-IN2P3 Université de Nantes) BP 20722-44307 Nantes France Laboratoire Leprince-Ringuet Ecole Polytechnique CNRS-IN2P3 Route de Saclay F-91128 Palaiseau France Oak Ridge National Laboratory Oak Ridge Tennessee 37831 USA Physics Department IHEP Protvino State Research Center of Russian Federation Institute for High Energy Physics Protvino 142281 Russia Collider-Accelerator Department Florida Institute of Technology Melbourne Florida 32901 USA Dapnia CEA Saclay F-91191 Gif-sur-Yvette France University of California-Riverside Riverside California 92521 USA Los Alamos National Laboratory Los Alamos New Mexico 87545 USA University of New Mexico Albuquerque New Mexico 87131 USA Abilene Christian University Abilene Texas 79699 USA Baruch College City University of New York New York New York 10010 USA PNPI Petersburg Nuclear Physics Institute Gatchina Leningrad region 188300 Russia Institut für

High-momentum two-particle correlations are a useful tool for studying jet-quenching effects in the quark-gluon plasma. Angular correlations between neutral-pion triggers and charged hadrons with transverse momenta in the range 4–12 GeV/c and 0.5–7 GeV/c, respectively, have been measured by the PHENIX experiment in 2014 for Au+Au collisions at sNN=200 GeV. Suppression is observed in the yield of high-momentum jet fragments opposite the trigger particle, which indicates jet suppression stemming from in-medium partonic energy loss, while enhancement is observed for low-momentum particles. The ratio and differences between the yield in Au+Au collisions and p+p collisions, IAA and ΔAA, as a function of the trigger-hadron azimuthal separation, Δϕ, are measured for the first time at the BNL Relativistic Heavy Ion Collider. These results better quantify how the yield of low-pT associated hadrons is enhanced at wide angle, which is crucial for studying energy loss as well as medium-response effects.

关键词： Particle correlations & fluctuations Relativistic heavy-ion collisions Hadrons Pions Hadron colliders

来源：评论

学校读者我要写书评

暂无评论

Genomic basis for RNA alterations in cancer (vol 578, pg 129, 2020)

引用

NATURE 2023年第7948期614卷 E37-E37页

作者： Calabrese, Claudia Davidson, Natalie R. Demircioglu, Deniz Fonseca, Nuno A. He, Yao Lehmann, Kjong-Van Liu, Fenglin Shiraishi, Yuichi Soulette, Cameron M. Urban, Lara Greger, Liliana Li, Siliang Liu, Dongbing Perry, Marc D. Xiang, Qian Zhang, Fan Zhang, Junjun Bailey, Peter Erkek, Serap Hoadley, Katherine A. Hou, Yong Huska, Matthew R. Kilpinen, Helena Korbel, Jan O. Marin, Maximillian G. Markowski, Julia Nandi, Tannistha Pan-Hammarstrom, Qiang Pedamallu, Chandra Sekhar Siebert, Reiner Stark, Stefan G. Su, Hong Tan, Patrick Waszak, Sebastian M. Yung, Christina Zhu, Shida Awadalla, Philip Creighton, Chad J. Meyerson, Matthew Ouellette, B. F. Francis Wu, Kui Yang, Huanming Brazma, Alvis Brooks, Angela N. Goke, Jonathan Ratsch, Gunnar Schwarz, Roland F. Stegle, Oliver Zhang, Zemin European Molecular Biology Laboratory European Bioinformatics Institute Hinxton UK European Molecular Biology Laboratory European Bioinformatics Institute (EMBL-EBI) Cambridge UK Genome Biology Unit European Molecular Biology Laboratory (EMBL) Heidelberg Germany CIBIO/InBIO - Research Center in Biodiversity and Genetic Resources Universidade do Porto Vairão Portugal Berlin Institute for Medical Systems Biology Max Delbruck Center for Molecular Medicine Berlin Germany German Cancer Consortium (DKTK) partner site Berlin Germany German Cancer Research Center (DKFZ) Heidelberg Germany Berlin Institute for Medical Systems Biology Max Delbrück Center for Molecular Medicine Berlin Germany German Cancer Consortium (DKTK) Partner site Berlin Berlin Germany European Molecular Biology Laboratory Genome Biology Unit Heidelberg Germany Division of Computational Genomics and Systems Genetics German Cancer Research Center (DKFZ) Heidelberg Germany ETH Zurich Zurich Switzerland Memorial Sloan Kettering Cancer Center New York NY USA Weill Cornell Medical College New York NY USA SIB Swiss Institute of Bioinformatics Lausanne Switzerland University Hospital Zurich Zurich Switzerland Computational Biology Center Memorial Sloan Kettering Cancer Center New York NY USA Department of Biology ETH Zurich Zürich Switzerland Department of Computer Science ETH Zurich Zurich Switzerland Korea University Seoul South Korea Computational and Systems Biology Program Memorial Sloan Kettering Cancer Center New York NY USA Department of Physiology and Biophysics Weill Cornell Medicine New York NY USA Institute for Computational Biomedicine Weill Cornell Medicine New York NY USA Controlled Department and Institution New York NY USA Englander Institute for Precision Medicine Weill Cornell Medicine New York NY USA National University of Singapore Singapore Singapore Genome Institute of Singapore Singapore Singapore Computational and Systems Biology Genome Institute of Singap

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：